News - Novartis, GlaxoSmithKline


Current filters:


Popular Filters

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly


In what looks like a significant restructuring of company focuses, Swiss drug major Novartis and UK peer…

Eli LillyGlaxoSmithKlineMergers & AcquisitionsNovartisPharmaceuticalVaccines

Factors driving oncologists’ prescribing decisions for HER2-positive breast cancer patients

Factors driving oncologists’ prescribing decisions for HER2-positive breast cancer patients


Efficacy, more than any other factors, drives oncologists’ prescribing of targeted therapies for breast…

AfinitorbuparlisibGlaxoSmithKlineHerceptinMarkets & MarketingNovartisOncologyPerjetaPharmaceuticalRocheTykerb

Pharma multinationals facing more pricing problems in India

Pharma multinationals facing more pricing problems in India


Even as a battle royal appears to be brewing between India's drug price regulator, the National Pharma…


Renal cell cancer market to rapidly decline from 2019

Renal cell cancer market to rapidly decline from 2019


The renal cell cancer market is expected to peak at a value of $2.7 billion in 2019, before significantly…

AfinitorAvastinBayerFinancialGlaxoSmithKlineInlytaMarkets & MarketingNexavarNorthern EuropeNovartisOncologyPfizerPharmaceuticalRocheSutentToriselUSAVotrient

Pharma figures high in EU R&D Investment Scoreboard, but led by US firms


Though not topping the league table, the pharmaceutical industry had a number of drugmakers among the…

EuropeFinancialGlaxoSmithKlineJohnson & JohnsonMerck & CoNorth AmericaNovartisPfizerPharmaceuticalResearchRocheSanofi

US NIH trials flu vaccines from Sanofi and Novartis

US NIH trials flu vaccines from Sanofi and Novartis


The US National Institutes of Health has begun testing an H7N9 avian influenza vaccine candidate in humans.

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalSanofi PasteurVaccines

Briefs: Roche deal with Chiasma; Vasella payout; FDA priority review for dolutegravir


Swiss drug major Roche (ROG: SIX) has entered into an agreement to develop and commercialize privately…

Anti-viralsdolutegravirGlaxoSmithKlineLicensingManagementNovartisOctreotide AcetatePharmaceuticalRare diseasesRegulationRocheViiV Healthcare

Patient trust in drugmakers declining, new report shows


Increasing numbers of pharmaceutical companies are seeking to redefine their relationships with patients,…

Abbott LaboratoriesBiotechnologyEli LillyGilead SciencesGlaxoSmithKlineGlobalJanssenLundbeckMarkets & MarketingNovartisNovo NordiskPfizerPharmaceuticalPricingResearchRoche

News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis


French drug major Sanofi (Euronext: SAN) has entered into a binding agreement to acquire the animal health…

BayerDosch PharmaceuticalsExjadeFlonaseGlaxoSmithKlineLegalMergers & AcquisitionsMerialNovartisOncologyPharmaceuticalregorafenibRegulationRespiratory and PulmonarySanofi

US FDA approvals for Signifor, raxibacumab and Iclusig


In a flurry of activity from the US Food and Drug Administration on Friday, the agency - which looks…

Antibiotics and Infectious diseasesAriad PharmaceuticalsGlaxoSmithKlineIclusigNorth AmericaNovartisOncologyPharmaceuticalRare diseasesraxibacumabRegulationSignifor

Credit Suisse focus on new drugs for COPD


New data will be presented at the European Respiratory Society, due to take place in Vienna, Austria,…

aclidiniumAlmirallGlaxoSmithKlineNovartisPharmaceuticalQVA149ResearchRespiratory and PulmonaryTheravanceVecturaZephyr

US HHS creates new centers to develop, manufacture medical countermeasures


The US Department of Health and Human Services this week established three new centers to develop and…

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalResearchVaccines

US FDA backs new indications for Votrient and Afinitor


The US Food and Drug Administration last week gave its approval for new indications for currently marketed…

AfinitorGlaxoSmithKlineNorth AmericaNovartisOncologyPharmaceuticalRegulationVotrient

Gap in patent filings for biological and small-molecule drugs widening, says Withers & Rogers


The number of patent applications filed by leading pharmaceutical companies for biological drugs has…

Abbott LaboratoriesBiotechnologyGlaxoSmithKlineNovartisPatentsPfizerPharmaceuticalResearchSanofi

GSK and Novartis withdraw EU extended use applications for Tyverb and Fluad, respectively


The European Medicines Agency has been formally notified by UK pharma giant GlaxoSmithKline (LSE: GSK)…


Robust growth forecast for renal cell carcinoma market


The renal cell carcinoma drug market will experience robust 3.7% annual growth from 2010 to 2020 in the…

axitinibdovitinibGlaxoSmithKlineMarkets & MarketingNephrology and HepatologyNovartisOncologyPfizerPharmaceuticalSutentVotrient

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top